Female, n (%)
|
119 (66)
|
80 (52)
|
136 (70)
|
Age, mean (SD)
|
55.9 (14.6)
|
54.3 (17.2)
|
50.7 (26.4)
|
Symptom duration (months), median (IQR)
|
3.2 (1.8–6.8)
|
3.0 (1.0–6.2)
|
–
|
Current smokers, n (%)
|
38 (24)
|
29 (23)
|
17 (9)
|
BMI (kg/m2), median (IQR)
|
26.4 (23.7–29.4)
|
25.5 (22.9–27.9)
|
24.1 (22.3–26.3)
|
WHO BMI classification, n (%)
| | | |
Low-normal weight (BMI 18.5–24.9 kg/m2) (%)
|
75 (38)
|
66 (42)
|
115 (60)
|
Overweight (BMI 25.0–29.9 kg/m2) (%)
|
79 (41)
|
70 (44)
|
61 (32)
|
Obesity (BMI ≥ 30 kg/m2) (%)
|
41 (21)
|
23 (14)
|
17 (9)
|
CRP (mg/L), median (IQR)
|
9.8 (3.7–23.0)
|
4.0 (3.0–15.1)
|
NA
|
ACPA positivity, n (%)
|
107 (55)
|
6 (4)
|
NA
|
RF positivity, n (%)
|
120 (62)
|
27 (17)
|
NA
|